Merck (MRK) Stock Rallies as Big Money Moves In and Dividend Rises – November 28, 2025 Update
On Friday, 28 November 2025, Merck & Co., Inc. (NYSE: MRK) continued to trade near its 52‑week highs as a wave of fresh institutional filings, bullish research notes, and recent oncology approvals kept the spotlight firmly on the pharmaceutical giant.